Today is #WorldCancerDay. As a technology-focused biomanufacturing company, we are proud to support multiple partners within the oncology space. We remain committed to working alongside our partners to provide lifesaving treatments for cancer patients.
Pretty amazing that after 25 years Paul is convicted. I knew he was guilty all along and finally happy to see him get his verdict. Thanks to the podcast bringing this back into topic.
NEWS: We’re excited to share that we have entered into a collaboration with @MayoClinic to manufacture and deliver novel biotherapeutics for rare and complex conditions. Learn more here: https://t.co/fROxhOIRJs
#biologics#biomanufacturing
We are excited to announce the Department of Defense has awarded us a contract to develop a treatment for botulinum neurotoxins. Read more about this news here: https://t.co/ir8kglFtJu
#USDeptofDefense#Resilience#Alachua and #Botulinum
600 organizations, 55 elected officials and 120,000 California residents agree: We need to reverse the disastrous CPUC decision and protect rooftop solar. Join us in calling on @GavinNewsom to #SaveSolar. https://t.co/ygftjA58r6
Resilience is a technology-focused biomanufacturing company aiming to revolutionize the way medicines are made. Read the latest news about our work in vaccines, biologics, nucleic acids and cell & gene therapies: https://t.co/e7wYChKaDC
News: we acquired SwiftScale Biologics, a leader in cell-free protein synthesis, a biomanufacturing process that can produce drugs faster with greater scalability. This technology is a promising avenue to produce next-generation therapies -- read more: https://t.co/qRv83smNM1
We are excited to announce our collaboration with ATP's Intergalactic Therapeutics today - Resilience will manufacture products for Intergalactic's first in human clinical trials, and help advance their novel cell-free manufacturing. More info here: https://t.co/y1zZWKti5X